Title: | Associate Professor of Biology, Faculty Athletic Representative |
Phone: | (518) 292-1754 |
Email: | freytj@sage.edu |
Jennifer Freytag, Ph.D.
The Sage Colleges' Faculty Athletic Representative
Associate Professor, Biology
Science Building, Albany
518-292-1754
freytj@sage.edu
Research Interests
- Mechanisms of tumor metastasis
- Epithelial-to-mesenchymal transition in cancer cells
- Effects of growth factors on cell migration
- Gene expression changes in cancer development
Publications
Czekay RP, Wilkins-Port CE, Higgins SP, Freytag J, Overstreet JM, Klein RM, Higgins CE, Samarakoon R, and Higgins PJ. “PAI-1: An integrator or cell signaling and migration.” International Journal of Cell Biology. 2011. 2011: 562481.
Wilkins-Port CE, Freytag J, Higgins SP, and Higgins PJ. “PAI-1: a multifunctional SERPIN with complex roles in cell signaling and migration.” Cell Communication Insights. 2010. 3:1-10.
Freytag J, Wilkins-Port CE, Higgins CE, Higgins SP, Samarakoon R, and Higgins PJ. “PAI-1 mediates the TGF-b1+EGF-induced “scatter”-response in transformed human keratinocytes.” Journal of Investigative Dermatology. 2010. 130: 2179-2190.
Freytag J, Wilkins-Port CE, Higgins CE, Carlson JA, Noel A, Foidart JM, Higgins SP, Samarakoon R, and Higgins PJ. “PAI-1 regulates the invasive phenotype in human cutaneous squamous cell carcinoma.” Journal of Oncology. 2009. Article ID 963209.
Higgins SP, Samarakoon, R, Higgins, CE, Freytag J, Wilkins-Port, CE, and Higgins, PJ. “TGF-b1-induced expression of the anti-apoptotic PAI-1 protein requires EGFR-signaling.” Cell Communication Insights. 2009. 2: 1-11.
Wilkins-Port CE, Higgins CE, Freytag J, Higgins SP, Carlson JA, and Higgins PJ. “PAI-1 is a critical upstream regulator of the TGF-β1/EGF-induced invasive phenotype in mutant p53 human cutaneous squamous cell carcinoma.” Journal of Biomedicine and Biotechnology. 2007. Article ID 85208.
Invited Presentation
“PAI-1 is an early event in and is required for TGF- β1+EGF-induced phenotypic plasticity of ras-transformed human keratinocytes.” Minisymposium on Tumor Biology: Mechanisms of Tumor Progression, Invasion, and Metastasis, American Association for Cancer Research (AACR) 100th Annual Meeting, Denver, CO. April 2009.
Abstracts/Posters
Freytag J, Samarakoon R, and Higgins PJ. “TGF-β1-induced EGFR transactivation and subsequent PAI-1 expression requires ADAM17 and src activity.” Translational Oncology Research Symposium: Transforming Basic Science into Clinical Practice. Albany, NY. September 2010.
Freytag J, Higgins CE, Saramarkoon R, Higgins SP, Wilkins-Port CE, and Higgins PJ. “PAI-1 expression is an early event in and is necessary for growth factor-induced epithelial plasticity of human keratinocytes and requires TGF-b1-induced transactivation of EGFR.” Translational Symposium: Transforming Basic Science into Clinical Practice. Albany NY. October 2009.
Freytag J, Higgins CE, Samarakoon R, Higgins SP, and Higgins PJ. “Involvement of PAI-1 in growth factor-induced plasticity of pre-malignant human keratinocytes.” Translational Symposium: Transforming Basic Science into Clinical Practice. Albany, NY. September 2008.
Spaulding C, Freytag J, Kutz SM, Higgins PJ. “PAI-1 Expression is critical for TGF-b1+EGF-stimulated cell migration and wound closure of human keratinocytes.” North East Regional Sigma Xi Conference. Ithaca, NY. April 2008.
Cervone C, Kutz SM, Freytag J, Higgins PJ. “TGF-β1-stimulated transactivation of the EGF receptor is required for PAI-1 Expression.” North East Regional Sigma Xi Conference. Ithaca, NY. April 2007.